Literature DB >> 2643302

Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond.

M A Austin1.   

Abstract

Elevated plasma triglyceride has been found to be a univariate risk factor for coronary heart disease in many epidemiologic studies, but this increased risk is not independent of other lipid and lipoprotein measures. Rather than dismiss triglyceride as a risk factor, we can see this disparity between univariate and multivariate results as a clue to better understanding of the potential role of triglyceride in atherosclerosis. From a statistical point of view, triglyceride often is not a significant predictor of coronary heart disease in multivariate statistical models because of the large variation in triglyceride measurements and the strong inverse relation between HDL cholesterol and triglyceride. Heterogeneity in both the biologic mechanisms producing hypertriglyceridemia and the manifestations of cardiovascular disease complicates the study of triglyceride as a risk factor. recently, subclasses of both HDL and LDL have been shown to be related to triglyceride metabolism and may provide more precise variables for predicting risk. However, none of this evidence precludes the involvement of triglyceride in the development of atherosclerosis. The final answer as to whether triglyceride is a causal risk factor for coronary heart disease must come from the biologic sciences, and the complexity of the epidemiologic results likely reflects the intricate metabolic processes involved.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2643302     DOI: 10.1093/oxfordjournals.aje.a115130

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  50 in total

Review 1.  IDL, VLDL, chylomicrons and atherosclerosis.

Authors:  B G Nordestgaard; A Tybjaerg-Hansen
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance.

Authors:  R W Bergstrom; D L Leonetti; L L Newell-Morris; W P Shuman; P W Wahl; W Y Fujimoto
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

3.  The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.

Authors:  R W James; D Pometta
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

4.  Long term effects of ketogenic diet in obese subjects with high cholesterol level.

Authors:  Hussein M Dashti; Naji S Al-Zaid; Thazhumpal C Mathew; Mahdi Al-Mousawi; Hussain Talib; Sami K Asfar; Abdulla I Behbahani
Journal:  Mol Cell Biochem       Date:  2006-04-21       Impact factor: 3.396

Review 5.  n-3 fatty acids and lipoproteins: comparison of results from human and animal studies.

Authors:  W S Harris
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

6.  An observational study of the effect of two thiazolidinediones on blood lipid levels: Rosiglitazone and pioglitazone in routine clinical practice.

Authors:  Deborah Griffis; Trentnt McLaughlin; Riad Dirani; Rob Thwaites
Journal:  Curr Ther Res Clin Exp       Date:  2004-03

Review 7.  Clinical relevance of reducing triglycerides. Implications for ischaemic heart disease treatment.

Authors:  A N Nafziger
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

8.  Regional disparities in cardiovascular risk factors in France: a five-year analysis of the GAZEL cohort.

Authors:  P D Tran; A Leclerc; J F Chastang; M Goldberg
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

9.  Apolipoproteins AI/B/E gene polymorphism and their plasma levels in patients with coronary artery disease in a tertiary care-center of Eastern India.

Authors:  Santanu Biswas; Pradip K Ghoshal; Bhubaneswar Halder; Kajal Ganguly; Arup DasBiswas; Nripendranath Mandal
Journal:  Indian Heart J       Date:  2013-10-30

10.  Stat3β mitigates development of atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Jihyun Lee; William M Baldwin; Chih-Yuan Lee; Stephen Desiderio
Journal:  J Mol Med (Berl)       Date:  2013-04-26       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.